Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer

		Keywords:		ANG1005

		Phase:		Phase 1

		Treatment ID#s:		VT1872 NCT00539383

		Age Group:		Adults Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		07/24/2008

		Tumor Types:		Metastatic Brain Tumor


		Comments:

		Treatment Type:		Chemotherapy.

		Contact:		Columbia University Medical Center Steven Rosenfeld, MD Contact: Mary Ann Kral New York, NY 10032 Phone:212-305-7266 Click here to send an email MD Andreson Cancer Center Razelle Kurzrock, MD Contact: Dwana Sanders Houston, TX 77030 Phone:713-794-1290 Click here to send an email Cancer Therapy Research Center John Sarantopoulos, MD Contact: Lindsay Sondergeld San Antonio, TX 78245 Phone:210-450-3806 Click here to send an email

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By